The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tyrosine kinase inhibitor (TKI) therapy discontinuation in patients with CML in chronic phase: A US clinical practice perspective.
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Johannes E. Wolff
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Dominick Latremouille-Viau
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Novartis (Inst)
 
Annie Guerin
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Novartis (Inst)
 
Irina Pivneva
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Novartis (Inst)
 
Owanate Briggs
Employment - Novartis
 
George J. Joseph
Employment - Novartis
Stock and Other Ownership Interests - Amgen; Express Scripts; Pfizer
 
Ehab L. Atallah
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Pfizer
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - MEI Pharma